tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

CANF Stock Latest News

Join Can-Fite’s Exclusive Live Investor Webinar and Q&A Session on August 8
Press ReleasesJoin Can-Fite’s Exclusive Live Investor Webinar and Q&A Session on August 8
10h ago
CANF
Can-Fite Seeks FDA Nod for Cancer Drug Namodenoson
PremiumCompany Announcements
Can-Fite Seeks FDA Nod for Cancer Drug Namodenoson
6d ago
6K
CANF
Can-Fite BioPharma applies for FDA Orphan Drug Designation for namodenoson
PremiumThe Fly
Can-Fite BioPharma applies for FDA Orphan Drug Designation for namodenoson
6d ago
CANF
Can-Fite Applies for FDA Orphan Drug Designation for Namodenoson in the Treatment of Pancreatic Cancer
PremiumPress Releases
Can-Fite Applies for FDA Orphan Drug Designation for Namodenoson in the Treatment of Pancreatic Cancer
6d ago
CANF
Can-Fite BioPharma Shareholders Approve Key Proposals
PremiumCompany Announcements
Can-Fite BioPharma Shareholders Approve Key Proposals
14d ago
6K
CANF
Can-Fite Reports Positive Liver Cirrhosis Treatment Results
PremiumCompany AnnouncementsCan-Fite Reports Positive Liver Cirrhosis Treatment Results
16d ago
6K
CANF
Can-Fite announces improvement in patient with decompensated liver cirrhosis
PremiumThe Fly
Can-Fite announces improvement in patient with decompensated liver cirrhosis
16d ago
CANF
Improvement in Patient with Decompensated Liver Cirrhosis Upon Treatment with Namodenoson
PremiumPress Releases
Improvement in Patient with Decompensated Liver Cirrhosis Upon Treatment with Namodenoson
16d ago
CANF
Can-Fite Reports Breakthrough in Canine Arthritis Study
PremiumCompany Announcements
Can-Fite Reports Breakthrough in Canine Arthritis Study
19d ago
6K
CANF
Can-Fite partner reports results from osteoarthritis multicenter clinical study
PremiumThe Fly
Can-Fite partner reports results from osteoarthritis multicenter clinical study
19d ago
CANF
Can-Fite BioPharma Reschedules Annual Meeting
PremiumCompany Announcements
Can-Fite BioPharma Reschedules Annual Meeting
21d ago
6K
CANF
Can-Fite’s Namodenoson Shows Promising Liver Benefits
PremiumCompany Announcements
Can-Fite’s Namodenoson Shows Promising Liver Benefits
23d ago
6K
CANF
Can-Fite BioPharma announces findings on Namodenoson
PremiumThe FlyCan-Fite BioPharma announces findings on Namodenoson
23d ago
CANF
Can-Fite Advances Namodenoson in Pancreatic Cancer Trial
PremiumCompany Announcements
Can-Fite Advances Namodenoson in Pancreatic Cancer Trial
1M ago
6K
CANF
IRB approves Can-Fite’s study of efficacy of Namodenoson in treatment of PC
PremiumThe Fly
IRB approves Can-Fite’s study of efficacy of Namodenoson in treatment of PC
1M ago
CANF
IRB approves Can-Fite’s study of efficacy of Namodenoson in treatment of PC
PremiumThe Fly
IRB approves Can-Fite’s study of efficacy of Namodenoson in treatment of PC
1M ago
CANF
IRB approves Can-Fite’s study of efficacy of Namodenoson in treatment of PC
PremiumThe Fly
IRB approves Can-Fite’s study of efficacy of Namodenoson in treatment of PC
1M ago
CANF
Can-Fite Reports Progress in Liver Cancer Drug Trial
PremiumCompany Announcements
Can-Fite Reports Progress in Liver Cancer Drug Trial
1M ago
6K
CANF
Can-Fite BioPharma announces update on Namodenoson
PremiumThe Fly
Can-Fite BioPharma announces update on Namodenoson
1M ago
CANF
Can-Fite’s Drugs Show Promise for Heart Health
PremiumCompany AnnouncementsCan-Fite’s Drugs Show Promise for Heart Health
2M ago
6K
CANF
Can-Fite BioPharma Ltd (CANF) Q1 Earnings Cheat Sheet
PremiumPre-Earnings
Can-Fite BioPharma Ltd (CANF) Q1 Earnings Cheat Sheet
2M ago
CANF
Can-Fite BioPharma AGM Set for June 2024
PremiumCompany Announcements
Can-Fite BioPharma AGM Set for June 2024
2M ago
6K
CANF

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >